ArticlePloS one2020

Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting.

Hsu-Heng Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.